马国
临床药学与药事管理, 副教授, 硕士生导师

      

   马  国

      

      

   副教授

      

博士

      

     021-51980025

      

021-51980025

电子邮件

     mg0328@126.com;  mg0328@fudan.edu.cn

通讯地址

   上海市浦东新区张衡路826号,复旦大学药学院科研楼东辅楼210

 
 

    

个人简介 

复旦大学药学院临床药学教研室副教授,硕士生导师。毕业于四川大学华西药学院,获药剂学专业博士学位。2010-2011年以国家公派访问学者身份留学美国University of Houston药学院。主要从事临床药学、药物动力学与分子药剂学研究。近年主持国家和省部级项目10余项,其中国家自然科学基金面上项目2项,上海市卫计委面上项目2项,教育部中央高校青年教师能力提升项目1项,复旦药学院-闵行医院融合基金1项,中华医学会和中国高等教育学会教改课题4项,上海市教委教育科学研究项目1项,复旦大学教学研究与改革实践项目1项,企业委托课题5项;主要参与国家自然科学基金等纵向和横向课题10多项;发表学术论文54篇,其中SCI论文24篇,中文核心期刊论文30篇。主编《临床药学导论》,副主编《药学服务概论》和《药学服务实务》,参编《临床药学理论与实践》等教材专著10部。以第一或通讯作者荣获国际会议优秀论文一等奖3项,教育部高等学校药学类专业指导委员会“2018全国药学院校教学学术研讨会优秀论文奖1项,中国中医药信息研究会中药临床药学分会优秀论文二等奖2项,中华医学会全国百篇优秀教学论文三等奖1项,上海市教学成果二等奖1项,复旦大学教学成果一等奖1项、二等奖1项,复旦大学上海医学院第四届PBL教案撰写大赛三等奖1项;荣获一健康基金优秀教师奖和复旦-复星健康梦基金上海医学院优秀教师奖。现为中国药学会循证药学专委会委员,中国中医药研究促进会中药临床药学分会常务理事,中国中医药信息研究会中医临床药学分会常务理事,中国民族医药学会科普分会理事,上海市药物代谢专业委员会委员,国家自然基金评审专家、中国药学会高级会员、ACSISSX、中国毒理学会、中国生物物理学会和上海市药学会会员;担任ECPT, MJPR, MJNDR, IJCPP, IJPC,《药学研究》等杂志编委;担任CDMCPASciPharmJCLM IJPC《中国临床药学杂志》、《药学研究》等杂志论文评阅专家。


研究方向

(1)中西药ADME/Tox及其调控

(2)转运体和代谢酶介导的药物相互作用

(3)药物代谢组学

4)降糖药物的研究开发


教育经历

·  2004年9月-2007年6月,四川大学华西药学院,药剂学专业,理学博士

·  2001年9月-2004年6月,原国家药监局四川抗菌素工业研究所,药剂学专业,理学硕士

·  1992年9月-1996年6月,原山东医科大学药学院,药学专业

 

工作经历

·  2014年12月-至今,复旦大学药学院,副教授,硕士生导师

·  2007年8月-2014年12月,复旦大学药学院,讲师

·  2010年12月-2011年12月,美国University of Houston药学院,访问学者

·  1996年8月-2001年8月,山东省泰安市夏张医院药剂科,药师

 

科研项目

1.主持国家自然科学基金面上项目——“基于细胞药代动力学与代谢组学的茵陈退黄机制与药效物质基础研究No.8137307820191月-202012月)

2.主持国家自然科学基金面上项目——“基于OATPs/UGT1A1/MRPs调控研究何首乌对胆红素代谢转运的影响及其肝毒性机理No.8137405120141月-201712月)

3.主持上海市卫生和计划生育委员会科研课题——基于转运体和代谢酶介导的胆红素/胆汁酸转运代谢调控研究茵陈退黄机制与药效物质基础(面上项目,No. 201740094 20181-202012月)

4.主持上海市卫生和计划生育委员会中医药科研课题——基于OATPs/UGT1A1/MRPs介导的胆红素转运代谢调控研究茵栀黄方退黄机制与药效物质基础(普通类课题,No. 2018YP001, 20191-202012月)

5. 主持教育部中央高校基本科研业务费青年教师能力提升项目基于OATP1B1/UGT1A1/MRP2调控研究中药(何首乌)对胆红素代谢转运的影响及其肝毒性机制No.2052013353120131月-201612月)

6. 主持复旦大学附属中山医院闵行分院-复旦大学药学院战略合作融合基金基于转运体和代谢酶介导的胆红素转运代谢调控研究茵栀黄方退黄机制与药效物质基础NO. RO-MY201707, 20181-201912月)

7. 主持中国首个IDO抑制剂---肿瘤免疫治疗药物TQ004TQ016的临床前药动学研究(20161-20166月)

8. 主持无锡天夏超声设备股份有限公司横向课题种新型超声波水的安全性评价与通便功能研究NO. CXF0080111201411月-20154月)


教改课题

1. 主持中华医学会医学教育分会、中国高等教育学会医学教育专业委员会2018年医学教育研究立项课题 ——“高层次临床药学人才培养模式创新与实践重点课题,A类,课题编号2018A-N1901420191-202012月)

2. 主持上海市教育委员会2019年度上海市教育科学研究项目” ——“基于健康中国需求的高层次临床药学人才创新培养模式的探索与实践20191-2021 12月)

3. 主持复旦大学2019年度第一批本科教学研究与改革实践项目——以学为中心,以学习成效为导向的 《临床药学技能与实践》课程学习活动设计与实施B类,项目编号:2019B02020191-202012

4. 主持中国高等教育学会药学教育研究会“2012药学教育改革研究课题”——“2+2+2”临床药学专业教育新模式的研究与实践(No. 20123720131-201412月)

5. 主持中国高等教育学会药学教育研究会“2010药学教育改革研究课题”——“临床药学专业课程与教学体系研究(重点课题,No. 201016 20111-201212月)

6.主持中国高等教育学会药学教育研究会“2008药学教育改革研究课题”——“临床药学人才培养模式研究与实践(重点课题,No. 20081720091-201012月)

7. 主持普通高等教育"十三五"规划教材暨数字化项目——临床药学导论(中国科技出版传媒股份有限公司,20165-20177月)

8. 主持复旦大学提高本科教育质量研究”——临床药学学科调查研究(20131-201312月)


教材专著

1. 主编《临床药学导论》(普通高等教育十三五规划教材,科学出版社,ISBN 978-7-03-053001-120177月)

2. 副主编《药学服务概论》(全国高等学校药学专业第八轮规划教材,国家卫生和计划生育委员会十三五规划教材,人民卫生出版社,ISBN 978711722187020162月)

3. 副主编《药学服务实务》(全国普通高等医学院校药学类专业十三五国家级规划教材,中国医药科技出版社,ISBN 97875067788862016110日)

4. 参编《临床药学理论与实践》(人民卫生出版社;ISBN 978711715085920123月)

5. 参编《临床药物治疗学总论》(人民卫生出版社;ISBN 9787117227469201711日)

6. 参编《药理学》(复旦大学出版社;ISBN9787309117271201661日)

7. 参编《循证药学》(全国高等学校药学类规划教材,高等教育出版社,2018年)

8. 参编《临床药学概论》(全国高等医药院校案例版规划教材,科学出版社,2018年)

9. 参编《药学科研思维与方法》(全国高等学校药学类专业研究生规划教材,人民卫生出版社,2018年)

10. 参编《临床药物治疗学》(中国医学教育题库,人民卫生出版社,2018年)


 

代表性SCI论文

1.Guo Ma, Ying Zhang, Wenyan Chen, Zhifang Tang, XiaomingXin, Ping Yang, Xiaoqin Liu,WeiminCai, Ming Hu. Inhibition of Human UGT1A1-Mediated Bilirubin Glucuronidation by Polyphenolic Acids Impact Safety of Popular Salvianolic Acid A/B-Containing Drugs and Herbal Products, Mol Pharm, 2017,14(9):2952-2966 (IF 4.440)

2. Guo Ma, Baojian Wu, Song Gao, Zhen Yang, Yong Ma, Ming Hu. Mutual regioselective inhibition of human UGT1A1-mediated glucuronidation of four flavonoids. Mol Pharm, 2013,10(8):2891-2903 (IF 4.787)

3. Guo Ma, Jiayuan Lin, Weimin Cai, Bo Tan, Xiaoqiang Xiang,Ying Zhang, Peng Zhang.Simultaneous determination of bilirubin and its glucuronides in liver microsomes and recombinant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirubin glucuronidation studies. J Pharm Biomed Anal, 2014,92:149-159 (IF3.225)

4.Guo Ma,Lin Zhang, Peng Zhang, XingfeiBao, Ning Zhou, Qingling Shi, Yuanting Zheng, Hongrui Liu, Fengjiao Bu, Ying Zhang, Wenjie Huang, Fen Wang, Yizhun Zhu*, WeiminCai*. Physicochemical characteristics and gastrointestinal absorption behaviors of S-propargyl-cysteine, a potential new drug candidate for cardiovascular protection and antitumor treatment.Xenobiotica2015, 45(4): 322-334 IF 2.101)

5. Dengfeng Tang1, Guo Ma1(Co-first author), Luyan Zhang, Gang Chen. Graphene-epoxy composite electrode fabricated by in situ polycondensation for enhanced amperometric detection in capillary electrophoresis. J Chromatogr A, 2013,1316: 127-134 ( IF 4.258)

6. Guo Ma, Xue-Hua Jiang, Zhuochen, Jing Ren, Chen-Rui Li, Tai-Ming Liu. Simultaneous determination of vitexin-4″-O-glucoside and vitexin-2″-O-rhamnoside from hawthorn leaves flavonoids in rat plasma by HPLC method and its application to pharmacokinetic studies.J Pharm Biomed Anal, 2007, 44:243-249  (IF 3.255)

7. Zhe Zhang, Guo Ma (Co-first author), Caifu Xue, Hong Sun, ZitengWang, Xiaoqiang Xiang*,Weimin Cai**.Establishment of rat liver microsome-hydrogel system for in vitro phase II metabolism and its application to study pharmacological effects of UGT substrates, Drug Metabolism and Pharmacokinetics, 342):141-147SCI, IF 2.087

8. Hong Sun, Xi Guo, Ziteng Wang, Peipei Wang, Zhe Zhang, Jihong Dong, Rongyuan Zhuang, Yuhong Zhou, Guo Ma,* and Weimin Cai*. Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway. Oxidative Medicine and Cellular Longevity. 2019:3142732 SCI, IF 4.936

9. Chen H, Liu J, Zhou Y, Hou Y, Ma G*, Cai W*.Association of hepatic nuclear factor 4 alpha gene polymorphisms with free Imatinib plasma levels and adverse reactions in Chinese gastrointestinal stromal tumor patients. Ther Drug Monit. 2019 Apr 25. doi: 10.1097/FTD.0000000000000642

10. Ye Liu, Yuping Liu, Xiaoyu Qiu, Qing Yang, Xuan Huang, Guo Ma*. Medication Therapy Management of a Rectal Cancer Patient with Multiple Organ Metastasis. EC Pharmacol Toxicol. 2019, 7(6):460-471

11. Shu-Shan Wu, Xiao-Yan Qiu, Yu-ping Liu, Ming-Ming Yan*, Guo Ma*. Management of Heparin-Induced Thrombocytopenia in a Hemodialysis Patient with End Stage Renal Disease and Acute Heart Failure. 2019, International Journal of Clinical Pharmacology & Pharmacotherapy (accepted)

12. Zheng YT, Zhu JH, Ma G, Zhu Q, Yang P, Tan B, Zhang JL, Shen HX, Xu JL, Zhu YZ, Cai WM. Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats. Acta Pharmacol Sin. 2012, 33(6):839-844. (IF 2.496)

13. Zheng YT, Xu JL, Ma G, Zhang JL, Zhu Q, Liu HR, Zhang P, Zhu YZ, Cai WM. Bioavailability and pharmacokinetics of S-propargyl-L-cysteine, a novel cardioprotective agent, after single and multiple doses in Beagle dogs. Xenobiotica, 2012, 43(3): 304-9. (IF 2.101)

14. Zhu X, Zhang X, Ma G, Yan J, Wang H, Yang Q.Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 inCaco-2 cells, J Pharm Pharm Sci2011,14(3):325-335.( IF 1.811)

15. Zhu Q, Cai W, Sha X, Ma G, Zheng Y, Shi X, Zhu Y. Quantification of leonurine, a novel potential cardiovascular agent, in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in rats. Biomed Chromatogr. 2012, 26(4):518-523. (IF 1.662)

16. Zheng YT, Liu H, Ma G, Yang P, Zhang L, Gu Y, Zhu Q, Shao T, Zhang P, Zhu Y, Cai W. Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC–MS/MS method and its application to pharmacokinetic studies. J Pharm Biomed Anal 2011,54(5): 1187-1197. (IF 3.225)

17. Bo Tan, Weimin Cai, Jinlian Zhang, Ning Zhou, Guo Ma, Ping Yang, Qing Zhu, Yizhun Zhu. Identification of UDP-glucuronosyltransferase isoforms responsible for leonurine glucuronidation in human liver and intestinal microsomes. Xenobiotica,2014,44(9):775-784 ( IF 2.101)    

18. Liu T, Chen Z, Guo Y, Jiang X, Ma G.Determination of tectoridin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies. Biomed Chromatogr. 2009, 23(7): 754-758. ( IF 1. 945)

19.Zhang Y, Jiang XH, Hu YQ, Li ZR, Su L, Wang ZG,Ma G. MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males. Br J Clin Pharmacol, 2008,66 (2):247-254 ( IF 3. 688)

20.Ren J, Jiang X, Li C,Li K, Chen Z, Ma G. Absorptive profile of chlorogenic acid in rats. Pharmazie. 2007, 62(9):689-92   (IF 1.126)

21. Zhang H, Bu F, Li L, Jiao Z, Ma G, Cai W, Zhuang X, Lin HS, Shin JG, Xiang X. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling. Basic Clin Pharmacol Toxicol. 2018;122(3):331-340  (IF 3.176 )

22. Wang P, Zhang C, Lv Q, Bao C, Sun H, Ma G, Fang Y, Yi Z, Cai W*. Association of DNA methylation in BDNF with escitalopram treatment response in depressed Chinese Han patients. Eur J Clin Pharmacol. 2018, 74(8):1011-1020

23. Xue CF, Zhang Z, Jin Y, Zhu B, Xing JF, Ma G, Xiang XQ, Cai WM. Novel in vitro dynamic metabolic system for predicting the human pharmacokinetics of tolbutamide. Acta Pharmacol Sin. 2018;39(9):1522-1532

1.Guo Ma, Ying Zhang, Wenyan Chen, Zhifang Tang, XiaomingXin, Ping Yang, Xiaoqin Liu,WeiminCai, Ming Hu. Inhibition of Human UGT1A1-Mediated Bilirubin Glucuronidation by Polyphenolic Acids Impact Safety of Popular Salvianolic Acid A/B-Containing Drugs and Herbal Products, Mol Pharm, 2017,14(9):2952-2966 (IF 4.440)

2. Guo Ma, Baojian Wu, Song Gao, Zhen Yang, Yong Ma, Ming Hu. Mutual regioselective inhibition of human UGT1A1-mediated glucuronidation of four flavonoids. Mol Pharm, 2013,10(8):2891-2903 (IF 4.787)

3. Guo Ma, Jiayuan Lin, Weimin Cai, Bo Tan, Xiaoqiang Xiang,Ying Zhang, Peng Zhang.Simultaneous determination of bilirubin and its glucuronides in liver microsomes and recombinant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirubin glucuronidation studies. J Pharm Biomed Anal, 2014,92:149-159 (IF3.225)

4.Guo Ma,Lin Zhang, Peng Zhang, XingfeiBao, Ning Zhou, Qingling Shi, Yuanting Zheng, Hongrui Liu, Fengjiao Bu, Ying Zhang, Wenjie Huang, Fen Wang, Yizhun Zhu*, WeiminCai*. Physicochemical characteristics and gastrointestinal absorption behaviors of S-propargyl-cysteine, a potential new drug candidate for cardiovascular protection and antitumor treatment.Xenobiotica2015, 45(4): 322-334 IF 2.101)

5. Dengfeng Tang1, Guo Ma1(Co-first author), Luyan Zhang, Gang Chen. Graphene-epoxy composite electrode fabricated by in situ polycondensation for enhanced amperometric detection in capillary electrophoresis. J Chromatogr A, 2013,1316: 127-134 ( IF 4.258)

6. Guo Ma, Xue-Hua Jiang, Zhuochen, Jing Ren, Chen-Rui Li, Tai-Ming Liu. Simultaneous determination of vitexin-4″-O-glucoside and vitexin-2″-O-rhamnoside from hawthorn leaves flavonoids in rat plasma by HPLC method and its application to pharmacokinetic studies.J Pharm Biomed Anal, 2007, 44:243-249  (IF 3.255)

7. Zhe Zhang, Guo Ma (Co-first author), Caifu Xue, Hong Sun, ZitengWang, Xiaoqiang Xiang*,Weimin Cai**.Establishment of rat liver microsome-hydrogel system for in vitro phase II metabolism and its application to study pharmacological effects of UGT substrates, Drug Metabolism and Pharmacokinetics, 342):141-147SCI, IF 2.087

8. Hong Sun, Xi Guo, Ziteng Wang, Peipei Wang, Zhe Zhang, Jihong Dong, Rongyuan Zhuang, Yuhong Zhou, Guo Ma,* and Weimin Cai*. Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway. Oxidative Medicine and Cellular Longevity. 2019:3142732 SCI, IF 4.936

9. Chen H, Liu J, Zhou Y, Hou Y, Ma G*, Cai W*.Association of hepatic nuclear factor 4 alpha gene polymorphisms with free Imatinib plasma levels and adverse reactions in Chinese gastrointestinal stromal tumor patients. Ther Drug Monit. 2019 Apr 25. doi: 10.1097/FTD.0000000000000642

10. Ye Liu, Yuping Liu, Xiaoyu Qiu, Qing Yang, Xuan Huang, Guo Ma*. Medication Therapy Management of a Rectal Cancer Patient with Multiple Organ Metastasis. EC Pharmacol Toxicol. 2019, 7(6):460-471

11. Shu-Shan Wu, Xiao-Yan Qiu, Yu-ping Liu, Ming-Ming Yan*, Guo Ma*. Management of Heparin-Induced Thrombocytopenia in a Hemodialysis Patient with End Stage Renal Disease and Acute Heart Failure. 2019, International Journal of Clinical Pharmacology & Pharmacotherapy (accepted)

12. Zheng YT, Zhu JH, Ma G, Zhu Q, Yang P, Tan B, Zhang JL, Shen HX, Xu JL, Zhu YZ, Cai WM. Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats. Acta Pharmacol Sin. 2012, 33(6):839-844. (IF 2.496)

13. Zheng YT, Xu JL, Ma G, Zhang JL, Zhu Q, Liu HR, Zhang P, Zhu YZ, Cai WM. Bioavailability and pharmacokinetics of S-propargyl-L-cysteine, a novel cardioprotective agent, after single and multiple doses in Beagle dogs. Xenobiotica, 2012, 43(3): 304-9. (IF 2.101)

14. Zhu X, Zhang X, Ma G, Yan J, Wang H, Yang Q.Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 inCaco-2 cells, J Pharm Pharm Sci2011,14(3):325-335.( IF 1.811)

15. Zhu Q, Cai W, Sha X, Ma G, Zheng Y, Shi X, Zhu Y. Quantification of leonurine, a novel potential cardiovascular agent, in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in rats. Biomed Chromatogr. 2012, 26(4):518-523. (IF 1.662)

16. Zheng YT, Liu H, Ma G, Yang P, Zhang L, Gu Y, Zhu Q, Shao T, Zhang P, Zhu Y, Cai W. Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC–MS/MS method and its application to pharmacokinetic studies. J Pharm Biomed Anal 2011,54(5): 1187-1197. (IF 3.225)

17. Bo Tan, Weimin Cai, Jinlian Zhang, Ning Zhou, Guo Ma, Ping Yang, Qing Zhu, Yizhun Zhu. Identification of UDP-glucuronosyltransferase isoforms responsible for leonurine glucuronidation in human liver and intestinal microsomes. Xenobiotica,2014,44(9):775-784 ( IF 2.101)    

18. Liu T, Chen Z, Guo Y, Jiang X, Ma G.Determination of tectoridin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies. Biomed Chromatogr. 2009, 23(7): 754-758. ( IF 1. 945)

19.Zhang Y, Jiang XH, Hu YQ, Li ZR, Su L, Wang ZG,Ma G. MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males. Br J Clin Pharmacol, 2008,66 (2):247-254 ( IF 3. 688)

20.Ren J, Jiang X, Li C,Li K, Chen Z, Ma G. Absorptive profile of chlorogenic acid in rats. Pharmazie. 2007, 62(9):689-92   (IF 1.126)

21. Zhang H, Bu F, Li L, Jiao Z, Ma G, Cai W, Zhuang X, Lin HS, Shin JG, Xiang X. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling. Basic Clin Pharmacol Toxicol. 2018;122(3):331-340  (IF 3.176 )

22. Wang P, Zhang C, Lv Q, Bao C, Sun H, Ma G, Fang Y, Yi Z, Cai W*. Association of DNA methylation in BDNF with escitalopram treatment response in depressed Chinese Han patients. Eur J Clin Pharmacol. 2018, 74(8):1011-1020

23. Xue CF, Zhang Z, Jin Y, Zhu B, Xing JF, Ma G, Xiang XQ, Cai WM. Novel in vitro dynamic metabolic system for predicting the human pharmacokinetics of tolbutamide. Acta Pharmacol Sin. 2018;39(9):1522-1532

 

荣誉奖励

1. 荣获2018年度一健康基金优秀教师奖. (一健康基金委员会,2019327日)

2. 荣获复旦复星健康梦基金复旦大学上海医学院优秀教师奖(20181220日)

3. 荣获复旦大学上海医学院第四届PBL教案撰写大赛三等奖——参赛案例名称:宝宝不做小黄人”——新生儿黄疸(排名第1,复旦大学上海医学院,2019111日)

4. 荣获“2018全国药学院校教学学术研讨会优秀论文奖——高层次临床药学人才创新培养模式的探索与实践(排名第1,教育部高等学校药学类专业指导委员会与中国药学会药学教育指导委员会联合举办,2018730日,新疆 乌鲁木齐)

5. 荣获首届全国临床药学高峰论坛临床药学论文评选二等奖——上海市二、三级医院的医护人员对临床药学工作和临床药师认知情况的调查研究(排名第1,中国中医药信息研究会中医临床药学分会,沈阳,20181013日)

6. 荣获中国中医药信息研究会中医临床药学分会中医临床药学论文评选二等奖——多酚酸类成分通过抑制人UGT1A1介导的胆红素葡萄糖醛酸化影响含有丹酚酸A/B组分的药物和草药的安全性(排名第1,广州,20181122日)

7.荣获The First Presentation Award in the 2014 Shanghai Forum of DMPK——Inhibition of Human UGT1A1-Mediated Bilirubin Glucuronidation by Danshen (Salvia Miltiorrhiza) injection, Compound Danshen injection and their constituents(第1作者,中国药物代谢专业委员会,2014830-31,上海)

8.荣获The Excellence Award in the 8th ISDNP——Evaluating the In Vitro Inhibition of Human UGT1A1-Mediated Bilirubin Glucuronidation by Danshen (Salvia Miltiorrhiza) injection and Compound Danshen injection in Predicting Herb-Induced Jaundice and Hyperbilirubinemia(第1作者,Committee of ISDNP20141010-11,上海)

9.荣获The First Award of Excellent Paper in the 2016 Sino-American Forum of Clinical Pharmacy——Inhibition of Human UGT1A1-Mediated Bilirubin Glucuronidation by Salvianolic Acid A, Salvianolic Acid B and Polyphenolic Acid-rich Danshen (Salvia miltiorrhiza) Injections(第1作者,复旦大学药学院、国家新药筛选中心,2016527-29,上海)

10.荣获上海市中医药系统生物学研究生学术论坛优秀论文二等奖——Mutual Regioselective Inhibition of Human UGT1A1-Mediated Glucuronidation of Four Flavonoids(通讯作者,20171130,上海)

11.荣获第十一届全国大学生药苑论坛创新成果奖一等奖(高血压患者用药现状、认知与需求调查研究,2018-11-09 杭州,获奖人 刘玉萍 等,指导老师  马国)

12.荣获第十一届全国大学生药苑论坛优秀论文奖(高血压患者用药现状、认知与需求调查研究,2018-11-09 杭州,获奖人 刘玉萍 等,指导老师  马国)

13.荣获中华医学会医学教育分会和中国高等教育学会医学教育专业委员会“2013年度医学教育和医学教育管理百篇优秀论文三等奖——美国Pharm.D.教育及其对我国临床药学教育的启示(排名第1

14.荣获2017年上海市高等教育教学成果奖二等奖——临床药学人才培养模式的探索与创新(排名第32018319日)

15.荣获2017年度复旦大学教学成果一等奖——临床药学人才培养模式的探索与创新(排名第32018119日)

16.荣获复旦大学研究生教学成果二等奖——《临床药物治疗学》优质课程与教材建设(排名第5201211月)

 

打印 返回